These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10189688)
1. [Antiretroviral drugs 1998/1999]. Rieger A Wien Med Wochenschr; 1998; 148(23-24):567-76. PubMed ID: 10189688 [TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection. Fischl MA AIDS; 1999 Sep; 13 Suppl 1():S49-59. PubMed ID: 10546785 [TBL] [Abstract][Full Text] [Related]
5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
6. [Salvage therapy for HIV infection]. Salzberger B MMW Fortschr Med; 2005 Apr; 147 Spec No 1():32-7. PubMed ID: 16385870 [TBL] [Abstract][Full Text] [Related]
7. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV. Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy and resistance to antiretroviral drugs. Lange JM; van Leeuwen R Ethiop Med J; 2002 Apr; 40 Suppl 1():51-75. PubMed ID: 12802831 [TBL] [Abstract][Full Text] [Related]
9. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection. Lagnese M; Daar ES Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948 [TBL] [Abstract][Full Text] [Related]
10. [Salvage therapy in HIV infection]. Salzberger B MMW Fortschr Med; 2004 Apr; 146 Spec No 1():52, 54-5, 57. PubMed ID: 15373050 [TBL] [Abstract][Full Text] [Related]
11. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations. Wilson LE; Gallant JE Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245 [TBL] [Abstract][Full Text] [Related]
12. Genotypic resistance tests for the clinical management of patients with primary HIV infection. Narciso P; Lazzarin A Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588 [TBL] [Abstract][Full Text] [Related]
13. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection. Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic perspectives for once-daily antiretroviral therapy. Anderson PL Ann Pharmacother; 2004 Nov; 38(11):1924-34. PubMed ID: 15479772 [TBL] [Abstract][Full Text] [Related]
18. Current concepts in antiretroviral therapy failure. del Rio C Top HIV Med; 2006; 14(3):102-6. PubMed ID: 16946454 [TBL] [Abstract][Full Text] [Related]
19. Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions. Prescrire Int; 2008 Jun; 17(95):98-101. PubMed ID: 18623908 [TBL] [Abstract][Full Text] [Related]